glutathione metal binding to ligands: Cadmium complexes with revisited L-Glutathione vs. oxidized vs. Reduced

Issa G, Bidikin A, Venugopal S, Konopleva M, DiNardo C, Kadia T, Borthakur G , Jabbour E, Pemmaraju N, Yilmaz M, Short N, Maiti A, Sasaki K, Masarova L, Pierce S, Takashi K, Tang G, Loghavi S, Patel K, Andreeff M, Bhalla K, Garcia-Manero G, Ravandi F, Kantarjian H, Daver N

doi: 10.1136/bmjopen-2023-075049 2 JavalgekarMJuppBVivashLOBrienTJWrightDKJonesNCet al

NAD+ therapies can be administered in targeted clusters or as a monthly maintenance routine depending on your specific performance goals

Important distinction: "Legal to compound" under 503A is NOT the same as "FDA approved." An FDA-approved drug has gone through full clinical trials and received a New Drug Application (NDA) approval

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimers disease

In another study, researchers fed 24 people meals containing several types of protein, such as casein, soy, whey, alpha-lactalbumin, or gelatin